Showing results (31-40 of 104) with videos related to
Sort By:
Pageof 11
Cancer Treatment Reports|June 1, 1983
Cisplatin-induced changes in bleomycin eliminationG C Yee, W R Crom, J E Champion, et al.Drug Intelligence & Clinical Pharmacy|June 1, 1982
Clinical pharmacology of bleomycin and cisplatinW E Evans, G C Yee, W R Crom, et al.Head & Neck Surgery|November 1, 1981
Clinical pharmacology of bleomycin and cisplatinW E Evans, G C Yee, W R Crom, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Effect of hydration on methotrexate plasma concentrations in children with acute lymphocytic leukemiaM L Christensen, G K Rivera, W R Crom, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
Urinary N-acetyl-beta-D-glucosaminidase and serum creatinine concentrations predict impaired excretion of methotrexateM P Goren, R K Wright, M E Horowitz, et al.Clinical Pharmacology and Therapeutics|August 1, 1991
Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrineW R Crom, M V Relling, M L Christensen, et al.Clinical Pharmacology and Therapeutics|May 1, 1983
Bleomycin disposition in children with cancerG C Yee, W R Crom, F H Lee, et al.Pharmacotherapy|January 1, 1993
Measurement of Tc-99m DTPA serum clearance for estimating glomerular filtration rate in children with cancerJ H Rodman, D C Maneval, H L Magill, et al.Cancer Chemotherapy and Pharmacology|January 11, 1991
Pharmacokinetics of continuous-infusion amsacrine and teniposide for the treatment of relapsed childhood acute nonlymphocytic leukemiaW P Petros, J H Rodman, J Mirro, et al.Pharmacotherapy|January 1, 1990
Patterns of antibiotic use and expenditures during 7 years at a university hospitalC V Fletcher, D Metzler, P Borchardt-Phelps, et al.Pageof 11